Predilution sets for distributing antigens

Abstract

A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.

What is claimed is: 
     
         1 . A prediluted kit including a range of prediluted doses of allergens for dispensing to a patient, comprising:
 a plurality of end-use sealable containers of prediluted antigens, wherein each one of the plurality of end-use sealable containers includes:   an insert to fill space within the end-use sealable container; and   an insert bottle disposed within the insert, wherein the insert bottle provides an elongated interior in the end-use sealable container, the elongated interior having a volume corresponding to at least a dose and to dispose a prediluted antigen at an elevated level in the end-use sealable container for extraction.   
     
     
         2 . The prediluted kit of  claim 1 , further comprising a container having a plurality of receiving pockets, each being associated with one of a plurality of sequential diluted allergen levels all based on a base concentrate antigen. 
     
     
         3 . The prediluted kit of  claim 2 , wherein a National Drug Code (NDC) of the base concentrate antigen is indicated on the container. 
     
     
         4 . The prediluted kit of  claim 2 , wherein each of the plurality of end-use sealable containers includes only a single diluted antigen. 
     
     
         5 . The prediluted kit of  claim 2 , wherein each one of the plurality of end-use sealable containers is at a defined level and disposed in one of the plurality of receiving pockets. 
     
     
         6 . The prediluted kit of  claim 5 , wherein each of the end-use sealable containers contains only a single dose of diluted allergen, as defined by a medical professional. 
     
     
         7 . The prediluted kit of  claim 5 , wherein each of the plurality of end-use sealable containers includes more than one diluted antigen. 
     
     
         8 . The prediluted kit of  claim 7 , wherein a plurality of National Drug Codes (NDC) is indicated on the container, wherein each of the plurality of NDCs is associated with a base concentrate antigen of each of the more than one diluted antigen. 
     
     
         9 . The prediluted kit of  claim 5 , further comprising an indicator disposed in association with each of the plurality of receiving pockets indicating a dilution level of the associated one of the end-use sealable containers included therein. 
     
     
         10 . The prediluted kit of  claim 9 , wherein the indicator comprises a color code, there being a separate color code associated with each dilution level and wherein each of the end-use sealable containers associated with each of the dilution levels has a corresponding color code disposed there on. 
     
     
         11 . The prediluted kit of  claim 10 , wherein each one of the plurality of end-use sealable containers is prepackaged as already including the base concentrate antigen at a sequential dilution level diluted in accordance with a predetermined sequential dilution process to provide sequentially lower dilution levels for use in an allergy desensitization regimen. 
     
     
         12 . The prediluted kit of  claim 11 , wherein the base concentrate antigen includes at least one specific antigen. 
     
     
         13 . The prediluted kit of  claim 2 , wherein the base concentrate antigen includes at least one specific antigen. 
     
     
         14 . The prediluted kit of  claim 13 , wherein each one of the plurality of end-use sealable containers is prepackaged as already including the base concentrate antigen at a sequential dilution level diluted in accordance with a predetermined sequential dilution process to provide sequentially lower dilution levels for use in an allergy desensitization regimen. 
     
     
         15 . The prediluted kit of  claim 14 , wherein the plurality of end-use sealable containers are sterile. 
     
     
         16 . The prediluted kit of  claim 1 , wherein each of the plurality of end-use sealable containers includes only a single diluted antigen. 
     
     
         17 . The prediluted kit of  claim 1 , wherein each of the end-use sealable containers contains only a single dose of diluted allergen, as defined by a medical professional. 
     
     
         18 . The prediluted kit of  claim 1 , wherein each of the plurality of end-use sealable containers includes more than one diluted antigen. 
     
     
         19 . The prediluted kit of  claim 18 , further comprising a container housing the plurality of end-use sealable containers, wherein a plurality of National Drug Codes (NDC) is indicated on the container, wherein each of the plurality of NDCs is associated with a base concentrate antigen of each of the more than one diluted antigen. 
     
     
         20 . The prediluted kit of  claim 1 , wherein the plurality of end-use sealable containers are sterile.